Deqi Pharmaceutical-B (06996) grants 11.52 million restricted share units

Zhitongcaijing · 2d ago

According to the Zhitong Finance App, Deqi Pharmaceutical-B (06996) issued an announcement. On September 10, 2026 (grant date), the Company will grant 11.52 million restricted share units in accordance with the 2022 Restricted Share Unit Plan.

The specific purpose and goal of the 2022 Restricted Share Unit Plan is to recognize the contributions made by eligible participants and provide them with incentives to retain the Group's continuing operation and development effectiveness; and to attract suitable personnel to promote the Group's further development. The Company's Remuneration Committee believes that the granting of restricted share units is appropriate and in accordance with market practice and the various items of the 2022 restricted share unit plan.